Literature DB >> 10030594

Selective expression of purinoceptor cP2Y1 suggests a role for nucleotide signalling in development of the chick embryo.

M P Meyer1, J D Clarke, K Patel, A Townsend-Nicholson, G Burnstock.   

Abstract

Responses to extracellular nucleotides (e.g., ATP, ADP, etc.) have been demonstrated in a number of embryonic cell types suggesting they may be important signalling molecules during embryonic development. Here the authors describe for the first time the expression of a G-protein-coupled receptor for extracellular ATP, chick P2Y1 (cP2Y1), during embryonic development of the chick. During the first 10 days of embryonic development, cP2Y1 is expressed in a developmentally regulated manner in the limb buds, mesonephros, brain, somites, and facial primordia, suggesting that this receptor may have a role in the development of each of these systems.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10030594     DOI: 10.1002/(SICI)1097-0177(199902)214:2<152::AID-AJA5>3.0.CO;2-L

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  19 in total

1.  P2Y(1) purinoceptor-mediated Ca(2+) signaling and Ca(2+) wave propagation in dorsal spinal cord astrocytes.

Authors:  S R Fam; C J Gallagher; M W Salter
Journal:  J Neurosci       Date:  2000-04-15       Impact factor: 6.167

2.  Discovery of purinergic signalling, the initial resistance and current explosion of interest.

Authors:  G Burnstock
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  Purinergic signaling induces thrombospondin-1 expression in astrocytes.

Authors:  Minh D Tran; Joseph T Neary
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

Review 4.  Nucleotide signaling in nervous system development.

Authors:  Herbert Zimmermann
Journal:  Pflugers Arch       Date:  2006-04-25       Impact factor: 3.657

Review 5.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

6.  Differences in purinergic and voltage-dependent signalling during protein kinase Calpha overexpression- and culturing-induced differentiation of C2C12 myoblasts.

Authors:  Tamás Deli; Balázs I Tóth; Gabriella Czifra; Henrietta Szappanos; Tamás Bíró; László Csernoch
Journal:  J Muscle Res Cell Motil       Date:  2006-10-19       Impact factor: 2.698

7.  Expression of P2Y(6) receptors in the developing mouse skeletal muscle and after injury and repair.

Authors:  Donghui Chen; Wei Wang; Wei Guo; Qiang Yu; Geoffrey Burnstock; Cheng He; Zhenghua Xiang; Hongliang Zheng
Journal:  J Anat       Date:  2011-03-18       Impact factor: 2.610

Review 8.  Purinergic signaling in embryonic and stem cell development.

Authors:  Geoffrey Burnstock; Henning Ulrich
Journal:  Cell Mol Life Sci       Date:  2011-01-08       Impact factor: 9.261

9.  Expression of the P2Y1 nucleotide receptor in chick muscle: its functional role in the regulation of acetylcholinesterase and acetylcholine receptor.

Authors:  R C Choi; M L Man; K K Ling; N Y Ip; J Simon; E A Barnard; K W Tsim
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

10.  Opposing effects of P2X(7) and P2Y purine/pyrimidine-preferring receptors on proliferation of astrocytes induced by fibroblast growth factor-2: implications for CNS development, injury, and repair.

Authors:  Joseph T Neary; You-Fang Shi; Yuan Kang; Minh D Tran
Journal:  J Neurosci Res       Date:  2008-11-01       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.